This profile has not been claimed and data may not be accurate.
48th percentile
90th percentile
GSR Ventures partner and serial founder now leading Musely's prescription skincare growth
Credibility
Experience · 88th percentile
- Approximately 15+ years of investing experience, with GSR Ventures involvement dating back to the mid-2000s (capped at 15 years).
Relationship Matrix
Founder score
- 97%Probability of being accurate (97%)Current founder and CEO of Musely, a telehealth company specializing in prescription skincare.
- 97%Probability of being accurate (97%)Previously founded Baynote, a recommendation-software company.
- 95%Probability of being accurate (95%)Wikipedia page exists for Jack Jia, confirming public notability as an American entrepreneur and technologist.
- 92%Probability of being accurate (92%)Raised a total of approximately $20.7M across Trusper/Musely ($16M per SEC Form D) and Baynote ($4.7M per SEC Form D).
- 90%Probability of being accurate (90%)Exit: Baynote was acquired (confirmed via SEC Form D filings and multiple independent sources).
- 85%Probability of being accurate (85%)GitHub account is dormant: last public push was approximately 9.9 years ago to repo 'OBSocialUI'.
- 75%Probability of being accurate (75%)Crunchbase lists 4 founded organizations, and Jack Jia was a founding member at Interwoven alongside other co-founders.
- 62%Probability of being accurate (62%)GitHub account @Jack-Jia identified as belonging to Jack Jia.
- 62%Probability of being accurate (62%)GitHub account @Jack-Jia has been active for approximately 9 years (created January 2016).
- 60%Probability of being accurate (60%)Stack Overflow reputation of 5,539 places Jack Jia in the 5,000–24,999 tier.
- 60%Probability of being accurate (60%)Stack Overflow account identified for Jack Jia with 5,539 reputation.
- 45%Probability of being accurate (45%)Identified as a researcher on OpenAlex with an h-index of 6 and 302 citations, affiliated with Temple University.
Investor score
- 92%Probability of being accurate (92%)Publicly identified as an angel investor, with investments in early-stage venture funds including Rally Ventures, Webb Investment Network, TSVC, and GSR Ventures.
- 88%Probability of being accurate (88%)Partner at GSR Ventures, a recognized venture capital firm.
- 80%Probability of being accurate (80%)Active GP and fund manager through his partnership role at GSR Ventures.
- 80%Probability of being accurate (80%)Portfolio company Science Exchange was acquired by Waud Capital Partners.
- 78%Probability of being accurate (78%)Made at least 2 confirmed investments including myYogaTeacher and Science Exchange.
- 72%Probability of being accurate (72%)Approximately 15+ years of investing experience, with GSR Ventures involvement dating back to the mid-2000s (capped at 15 years).
What you likely need
You'd get the most out of Festival events that put you in rooms with strategic equity investors who can open distribution channels for Musely's DTC skincare model, and with operators who've scaled consumer health brands past the $100M revenue mark. Roundtables focused on formalizing angel activity into a named syndicate or micro-fund would also be high-signal, given your GSR Ventures track record and 15+ years of deal experience.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingA dinner with General Catalyst portfolio founders and co-investors exploring equity rounds to complement non-dilutive facilities — ideal for Jack to pressure-test Musely's strategic equity raise and surface distribution-channel partners
- hiringA hiring roundtable with DTC consumer-health founders who've scaled past $50M in revenue to trade referrals for world-class CMO candidates who understand compounded-treatment acquisition funnels
- introsA happy hour for GSR Ventures alumni and active angel investors looking to formalize deal flow into a named syndicate or micro-fund, with LPs already familiar with cross-border US-China tech investing
- positioningA Gold House founder roundtable with A100 honorees who've landed keynote slots at health-tech and DTC conferences, workshopping how to pair a personal founder narrative with a company's clinical brand
- tacticalA build-in-public dinner for telehealth and AI health-stack founders actively open-sourcing tooling — structured around sharing what's safe to publish from a HIPAA-adjacent codebase to rebuild a technologist brand on GitHub
- positioningAn AngelList and Crunchbase profile office hours session for active investors whose documented deal count dramatically understates their real portfolio, focused on which investments to surface publicly to attract inbound co-investment
- wellbeingA small dinner for serial founders simultaneously running active companies and investment portfolios — modeled on the Sequoia Arc wellness sessions — to share structured recovery practices and accountability systems for avoiding operator burnout
